Nubratori, Inc. 503B outsourcing facility · Torrance, CA
This is a record of what FDA published, not a rating. Last FDA inspection and Form 483 status below are as published in FDA's registered outsourcing facilities table (as of Sep 30, 2026).
FDA registration record
| Listed by FDA as | Nubratori, Inc., Torrance, CA |
|---|---|
| City / state | Torrance, CA FDA's table lists city and state only, not a street address. |
| Contact phone (as listed by FDA) | 310-218-4153 |
| Initial registration date | 2/24/2017 |
| Most recent registration date | 12/3/2025 Outsourcing facilities must re-register annually (Oct 1 – Dec 31) to remain on FDA's list. |
| Last inspection (FDA table) | 12/11/2025 |
| Form 483 issued at last inspection? | Yes · View Form 483 (FDA PDF) |
| Recall conducted? (FDA table) | No |
| Action based on last inspection | Warning Letter Closeout Issued 7/27/2026 FMD-145 Letter Issued 7/21/2026 “Open” means FDA has not determined whether further action will be taken (per FDA's table notes). |
| Intends to compound sterile drugs from bulk substances | Yes Self-reported by the facility at registration; FDA notes this information has not been verified by FDA. |
Published FDA records
Counts include only items from FDA's table or exact name + city + state matches. They are counts of published records, not a score. Uncertain matches are shown below but not counted.
State board of pharmacy license lookup
California State Board of Pharmacy (DCA License Search) (license lookup)
Search the state board's lookup for this facility's license status and any disciplinary actions. We link to the state-level tool only and do not list license numbers. FDA's table does not include state board actions. Facilities that ship across state lines may also hold non-resident licenses in your state, so check your own state's board too.
Verify directly
- FDA registered outsourcing facilities table
- FDA compounding inspections, recalls and other actions
- FDA Enforcement Report (recalls)
- FDA warning letter database
Represent this facility? Claim this profile. Claimed profiles never change FDA records.
Timeline of FDA actions
Newest first. Sources: FDA's registration table, FDA's compounding actions page (2019 onward on the live page), and openFDA drug enforcement records. Items marked Uncertain match may relate to a different site or entity and are not counted. How matching works.
-
Warning letter close-out FDA tableWarning Letter Closeout Issued 7/27/2026No document link published · FDA registered outsourcing facilities table
-
FMD-145 letter FDA tableFMD-145 Letter Issued 7/21/2026No document link published · FDA registered outsourcing facilities table
-
Inspection FDA tableLast inspection per FDA table; Form 483 issued: YesFDA document · FDA registered outsourcing facilities table
-
Form FDA 483 FDA tableForm FDA 483 (linked from FDA's registration table)FDA document · FDA registered outsourcing facilities table
-
Recall MatchedRecall event 96699Class II · Ongoing · 1 product line(s) · Recall no. D-0392-2025Recalling firm as listed: Nubratori, Inc, Torrance, CA. Reason: Labeling: Incorrect or Missing Lot and/or Expiration date: Individual vials of Dexonto 0.4%, are labeled correctly with the BUD of 12/25/2024, however, the outer box on some of the Dexonto 0.4% are labeled incorrectly with a BUD of 12/25/2025.openFDA record · openFDA drug enforcement API
-
Warning letter MatchedWarning Letter Issued 01/22/2025Listed on FDA page under: Nubratori Inc. dba Nubratori Rx, Torrance, CA - 503B FacilityFDA document · FDA Compounding: Inspections, Recalls, and other Actions
-
Form FDA 483 Matched483 Issued 07/26/2024 (PDF - 1.25MB)Listed on FDA page under: Nubratori Inc. dba Nubratori Rx, Torrance, CA - 503B FacilityFDA document · FDA Compounding: Inspections, Recalls, and other Actions
-
FMD-145 letter MatchedFMD-145 Letter Issued 05/06/2022Listed on FDA page under: Nubratori Inc. dba Nubratori Rx, Torrance, CA - 503B FacilityNo document link published · FDA Compounding: Inspections, Recalls, and other Actions
-
FMD-145 letter MatchedFMD-145 Letter Issued 09/21/2021Listed on FDA page under: Nubratori Inc. dba Nubratori Rx, Torrance, CA - 503B FacilityNo document link published · FDA Compounding: Inspections, Recalls, and other Actions
-
Form FDA 483 Matched483 Issued 09/26/2019 (PDF - 637KB)Listed on FDA page under: Nubratori Inc. dba Nubratori Rx, Torrance, CA - 503B FacilityFDA document · FDA Compounding: Inspections, Recalls, and other Actions
-
FMD-145 letter MatchedFMD-145 Letter Issued 05/15/2019 (PDF - 65KB)Listed on FDA page under: Nubratori Inc. dba Nubratori Rx, Torrance, CA - 503B FacilityFDA document · FDA Compounding: Inspections, Recalls, and other Actions